BIOMAT Database Logo BIOMAT Database Logo

Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). 1973

R C DeConti, and B R Toftness, and R C Lange, and W A Creasey

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010984 Platinum A heavy, soft, whitish metal, resembling tin, with atomic number 78, atomic weight 195.084, symbol Pt. It is used in manufacturing equipment for laboratory and industrial use. It occurs as a black powder (platinum black) and as a spongy substance (spongy platinum) and may have been known in Pliny's time as "alutiae". Platinum Black
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002712 Chlorides Inorganic compounds derived from hydrochloric acid that contain the Cl- ion. Chloride,Chloride Ion Level,Ion Level, Chloride,Level, Chloride Ion
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females

Related Publications

R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II).
February 1983, Cancer research,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Cisplatin (cis-diamminedichloroplatinum II).
March 1979, Cancer treatment reviews,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).
December 1972, Cancer,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Phase I clinical and pharmacological study of thymidine (NSC 21548) and cis-diamminedichloroplatinum(II) in patients with advanced cancer.
August 1986, Cancer research,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Renal handling of cis-diamminedichloroplatinum(II).
January 1980, Cancer treatment reports,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Gastrointestinal toxicity of cis-diamminedichloroplatinum (II).
January 1982, The Netherlands journal of medicine,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Gastrointestinal toxicity of cis-diamminedichloroplatinum (II).
January 1982, The Netherlands journal of medicine,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Nerve conduction studies in patients treated with cis-diamminedichloroplatinum(II): a preliminary report.
January 1980, Cancer treatment reports,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha.
August 1993, Cancer,
R C DeConti, and B R Toftness, and R C Lange, and W A Creasey
Interaction of cis-diamminedichloroplatinum (II) with mitochondrial phosphate carrier.
January 1985, Neoplasma,
Copied contents to your clipboard!